Jubilant Pharmova Limited (NSE:JUBLPHARMA)
India · Delayed Price · Currency is INR 978.15
+13.75 (1.43%)
Jun 29, 2026, 9:50 AM IST
Jubilant Pharmova Market Cap
Jubilant Pharmova has a market cap or net worth of 152.7 billion as of June 26, 2026. Its market cap has decreased by -15.38% in one year.
Market Cap
152.70B
Enterprise Value
176.20B
Revenue
82.80B
Ranking
n/a
PE Ratio
38.32
Stock Price
978.15
Market Cap Chart
Since May 30, 2000, Jubilant Pharmova's market cap has increased from 406.73M to 152.70B, an increase of 37,443.83%. That is a compound annual growth rate of 25.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 29, 2026 | 152.70B | -10.30% |
| Dec 31, 2025 | 170.24B | -2.67% |
| Dec 31, 2024 | 174.91B | 101.48% |
| Dec 29, 2023 | 86.81B | 45.28% |
| Dec 30, 2022 | 59.75B | -36.05% |
| Dec 31, 2021 | 93.44B | -30.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Wockhardt | 319.33B |
| Piramal Pharma | 222.67B |
| Eris Lifesciences | 202.17B |
| Cohance Lifesciences | 175.23B |
| NATCO Pharma | 161.86B |
| Alembic Pharmaceuticals | 151.65B |
| Alivus Life Sciences | 136.03B |
| Strides Pharma Science | 99.75B |